Advertisement

Policy Pitfalls and Challenges in Cannabis Regulation: Lessons from Colorado

  • Ned Calonge
Brief Report
  • 464 Downloads

Abstract

Since legalization of recreational marijuana use in 2012, Colorado has been a site of regulatory experimentation to support commercial sales. The path to legal recreational use began with a series of policy events that expanded the state’s medical marijuana program to include the creation of dispensaries and significantly increase the number of registered users. Voters convincingly passed a constitutional amendment that permitted commercial sale of recreational marijuana, and the state has created a regulatory model, based on a private business model, to address potential negative impacts. Colorado has used state- and local-level licensing, statues, and regulations to address regulatory challenges regarding product potency, cannabis edibles, worksite and worker issues, impaired driving, commercial growing operations, locations of outlets and sites of use, and other policy issues. Jurisdictions considering recreational legalizations should consider a “harm reduction” approach to regulation that is responsive to addressing evolving adverse effects and addresses child safety, traffic safety, cannabis product safety, work and worksite safety, and other aspects of the business model in order to provide a careful approach to recreational use.

Keywords

Cannabis Marijuana regulation Colorado 

Notes

Compliance with Ethical Standards

The article is in compliance with the protection of all human and animal rights.

Conflict of Interest

The author declares that there is no conflict of interest.

References

  1. Campbell, C. A., Hahn, R. A., Elder, R., Brewer, R., Chattopadhyay, S., Fielding, J., Naimi, T. S., Toomey, T., Briana Lawrence, B., & Middleton, J. C. (2009). Task Force on Community Preventive Services. The effectiveness of limiting alcohol outlet density as a means of reducing excessive alcohol consumption and alcohol-related harms. American Journal of Preventive Medicine, 37(6), 556–569.CrossRefPubMedGoogle Scholar
  2. Middleton, J. C., Hahn, R. A., Kuzara, J. L., Elder, R., Brewer, R., Chattopadhyay, S., Fielding, J., Naimi, T. S., Toomey, T., & Lawrence, B. (2010). Task Force on Community Preventive Services. Effectiveness of policies maintaining or restricting days of alcohol sales on excessive alcohol consumption and related harms. American Journal of Preventive Medicine, 39(6), 575–589.CrossRefPubMedPubMedCentralGoogle Scholar
  3. National Academies Institute of Medicine. (2000). Marijuana as medicine?: The science beyond the controversy. Alison Mack Janet Joy for the Institute of Medicine. Washington, DC: The National Academies Press dc21 00-046058.Google Scholar
  4. National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press.  https://doi.org/10.17226/24625.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Family Medicine, The Colorado TrustUniversity of Colorado School of MedicineDenverUSA

Personalised recommendations